ArticleBioengineering (Basel, Switzerland)2026
BMP-2-Loaded Self-Crosslinking CaP/Hydrogel Composite Enables Complete Regeneration of Critical-Sized Segmental Bone Defects.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Critical-size segmental bone defects remain a major challenge in orthopedic surgery, often requiring complex reconstruction strategies associated with significant morbidity. This study evaluated the regenerative potential of a self-crosslinking bone substitute (SCBS) composed of biphasic calcium phosphate (BCP) granules suspended in a silanized hydroxypropyl methylcellulose (Si-HPMC) hydrogel, with or without recombinant human bone morphogenetic protein-2 (rhBMP-2), in a canine load-bearing defect model. Bilateral 2-cm segmental defects were created in the ulnae of five adult beagle dogs. Defects were filled with SCBS alone or SCBS loaded with rhBMP-2. Bone regeneration and biomaterial remodeling were assessed after 20 weeks using micro-computed tomography (micro-CT), scanning electron microscopy (SEM), histomorphometry, elemental analysis, and histology. SCBS loaded with rhBMP-2 resulted in complete defect bridging, with 35% newly formed bone and only 5% residual BCP granules. In contrast, SCBS alone induced limited bone formation (10%), primarily at host interfaces, with substantial persistence of BCP (33%). Newly formed bone in the rhBMP-2 group exhibited a dense lamellar structure with Haversian organization and direct contact with residual biomaterial. Elemental analysis revealed a lower Ca/P ratio compared with control, suggesting ongoing remodeling. These findings demonstrate that controlled delivery of rhBMP-2 from a self-crosslinking CaP/hydrogel composite enhances both bone formation and biomaterial resorption, supporting a coupled regeneration process. This approach represents a promising strategy for the treatment of segmental bone defects and non-unions in orthopedic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.